TEL AVIV, Israel, Oct. 12, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will host an R&D Day on Wednesday, November 11, 2026. At the R&D Day, Teva’s leadership will discuss its R&D pipeline, its near-term value-creation potential over the next five years, and Teva’s ongoing transformation into an innovative biopharma company through the Pivot to Growth strategy. Read More
Source link
Eby slams U.S.-style health care privatization, Conservatives claim 'fearmongering'
DELTA — British Columbia NDP Leader David Eby took aim at the premier next door while campaigning in this month’s election, promising not to implement what he called the “U.S.-style…






